Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Testosterone Cypionate
Therapeutic Area : Oncology
Study Phase : Phase II
Sponsor : Dendreon
Deal Size : Inapplicable
Deal Type : Inapplicable
Sipuleucel-T Combined with Bipolar Androgen Therapy in Men with MCRPC
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
October 25, 2023
Lead Product(s) : Testosterone Cypionate
Therapeutic Area : Oncology
Highest Development Status : Phase II
Sponsor : Dendreon
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Testosterone Cypionate
Therapeutic Area : Oncology
Study Phase : Phase II
Sponsor : Bayer AG
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
September 22, 2020
Lead Product(s) : Testosterone Cypionate
Therapeutic Area : Oncology
Highest Development Status : Phase II
Sponsor : Bayer AG
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Testosterone Cypionate
Therapeutic Area : Endocrinology
Study Phase : Phase IV
Sponsor : Acerus Pharmaceuticals
Deal Size : Inapplicable
Deal Type : Inapplicable
A Comparison of Side Effects in Hypogonadal Men Treated With Natesto Versus Testosterone Injections
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
June 19, 2020
Lead Product(s) : Testosterone Cypionate
Therapeutic Area : Endocrinology
Highest Development Status : Phase IV
Sponsor : Acerus Pharmaceuticals
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Testosterone Cypionate
Therapeutic Area : Endocrinology
Study Phase : Phase I
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
A Bioequivalence Study of Testosterone Cypionate in Hypogonadal Males
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
January 03, 2019
Lead Product(s) : Testosterone Cypionate
Therapeutic Area : Endocrinology
Highest Development Status : Phase I
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Testosterone Cypionate
Therapeutic Area : Oncology
Study Phase : Phase II
Sponsor : Bristol Myers Squibb
Deal Size : Inapplicable
Deal Type : Inapplicable
COMbination of Bipolar Androgen Therapy and Nivolumab
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
June 13, 2018
Lead Product(s) : Testosterone Cypionate
Therapeutic Area : Oncology
Highest Development Status : Phase II
Sponsor : Bristol Myers Squibb
Deal Size : Inapplicable
Deal Type : Inapplicable